標(biāo)題:Research Grade Anti-RSV pre-F/pre-Fusion glycoprotein F0 (ADI-14442),AntibodySystem Laboratories
貨號:DVV02822
產(chǎn)品鏈接:http://www.antibodysystem.com/product/9575.html
物種反應(yīng)性:Human respiratory syncytial virus A (strain A2)
形式:Liquid
存儲緩沖區(qū):0.01M PBS, pH 7.4.
濃度:1 mg/ml
純度:>95% by SDS-PAGE.
克隆性:Monoclonal
應(yīng)用:Research Grade Biosimilar
儲存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
參考文獻(xiàn):
RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses. PMID: 36535957
Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein. PMID: 30769923
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. PMID: 27682426
Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring. PMID: 32197348
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates. PMID: 32045432
The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein. PMID: 31288455
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. PMID: 28604155
Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. PMID: 31623333
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. PMID: 32358170
Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. PMID: 26541285
Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection. PMID: 36986643
Epitope-Specific Serological Assays for RSV: Conformation Matters. PMID: 30813394
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. PMID: 37029694
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus. PMID: 27463224
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. PMID: 29765035
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle. PMID: 35773301
The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination. PMID: 33131932
Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats. PMID: 34941963
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus. PMID: 29073183
Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice. PMID: 29182682
Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge model. PMID: 36098319